Join Prof. Illidge, Prof. Scarisbrick, Prof. André, Prof. Janssens, Dr. Saevels, Dr. Woei-a-jin and Dr. Wolfromm as they discuss clinical trials and Belgian guidelines in T-cell malignancies.
This webinar also dives in to challenging clinical cases, and there will be an opportunity for you to put your questions forward to this expert panel.
Program:
20:00
Introduction
20:05
Peripheral T-Cell Lymphoma (PTCL)
Echelon-2 trial - Prof. Dr. Timothy Illidge (Manchester)
Belgian guidelines on PTCL - Dr. Alice Wolfromm (Erasme)
PTCL patient case - Prof. Marc André (Mont Godinne)
21:05
Cutaneous T-Cell Lymphoma (CTCL)
ALCANZA trial - Prof. Dr. Julia Scarisbrick (London)
CTCL patient case - Dr. Kirsten Saevels (Antwerp)
CTCL patient case - Dr. Sherida Woei-a-jin (Leuven)
We look forward to welcoming you to what we anticipate will be a thought-provoking and informative webinar.
If you have any questions, please do not hesitate to contact:
Bert Van Zeebroeck
Takeda Oncology
Key Account Manager
bert.van-zeebroeck@takeda.com
Carlo Pili
Takeda Oncology
Key Account Manager
carlo.pili@takeda.com
C-APROM/BE/ADCE/0042- date of creation August 2021